Tempus AI Inc (NASDAQ:TEM) shares are trading lower by 1.7% to $53.15 Tuesday afternoon. The company will report its first-quarter earnings after Tuesday's market close, with analysts expecting a loss of 27 cents per share on revenue of $248.13 million.
What To Know: Tuesday’s earnings report follows the Monday launch of Notetaker, an AI clinical assistant that streamlines psychiatric documentation by ambiently recording sessions and generating notes for electronic health records.
The tool, available via Tempus Hub, enhances the company's mental health platform with features like multilingual transcription, pharmacogenomic insights, and HIPAA-compliant data storage.
Tempus also recently deepened its strategic collaboration with AstraZeneca and Pathos AI to develop a multimodal foundation model in oncology, under a $200 million agreement aimed at improving cancer therapeutics using Tempus' de-identified data.
In the fourth-quarter, Tempus reported $200.68 million in revenue--up 35.8% year-over-year--and a narrower-than-expected loss of $0.18 per share. The company ended the quarter with $940 million in remaining contract value and forecasts strong 2025 growth, aiming for $1.24 billion in revenue and positive adjusted EBITDA.
Retail investor interest in Tempus has also increased in part due to notable options purchases by former House Speaker Nancy Pelosi earlier this year.
Read Also: Bessent Signals Imminent Trade Deals, Dismisses Recession Fears As Stocks Rebound
How To Buy TEM Stock
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in Tempus AI’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from Benzinga Pro, TEM has a 52-week high of $91.45 and a 52-week low of $22.89.
